QDEL
21.89
+11.51%↑
QDEL
21.89
+11.51%↑
QDEL
21.89
+11.51%↑
QDEL
21.89
+11.51%↑
QDEL
21.89
+11.51%↑
24h
Aktuell
Min
109.15
Max
113.45
Einkommen | -83M 652M |
|---|---|
Verkäufe | -25M 5.3B |
EPS | 2.07 |
Dividendenrendite | 1.34 |
Gewinnspanne | 12.407 |
Empfehlungen | Buy |
|---|---|
12-Monats-Prognose | +30.48% upside |
Dividendenrendite Branchendurchschnitt | 1.34% 2.33% |
|---|---|
Nächstes Ergebnis | 13. Nov. 2025 |
Marktkapitalisierung | 98B |
|---|---|
Vorheriger Eröffnungskurs | 110.07 |
Vorheriger Schlusskurs | 112.85 |
By Trading Central
Vertrauen
Strong Bearish Evidence
121.15 / 123.55 Unterstützung & Widerstand
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
1. Okt. 2025, 08:54 UTC
Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site
DJ
Lesen
7. Aug. 2025, 05:43 UTC
Germany's Merck Raises Earnings Growth Guidance, But Turns Cautious on Sales
DJ
Lesen
6. Nov. 2025, 21:52 UTC
Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED
DJ
Lesen
6. Nov. 2025, 21:51 UTC
Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany
DJ
Lesen
16. Okt. 2025, 08:34 UTC
Merck KGaA's Cost Cutting Likely Led to Profitability Target Raise -- Market Talk
DJ
Lesen
15. Okt. 2025, 12:08 UTC
Merck KGaA Didn't Disclose Financial Details
DJ
Lesen
15. Okt. 2025, 12:07 UTC
Merck KGaA: JSR's Amsphere Protein A Resin Tech Complements Existing Biologics Portfolio
DJ
Lesen
15. Okt. 2025, 12:07 UTC
Merck KGaA: Unit is Based in Belgium, Has 50+ Employees
DJ
Lesen
15. Okt. 2025, 12:06 UTC
Merck KGaA: Deal Will Strengthen Position in Bioprocessing Market
DJ
Lesen
15. Okt. 2025, 12:05 UTC
Merck KGaA: Definitive Agreement Signed Today
DJ
Lesen
15. Okt. 2025, 12:05 UTC
Merck KGaA: Transaction Expected to Close by End of 2Q 2026
DJ
Lesen
15. Okt. 2025, 12:04 UTC
Merck KGaA to Buy Chromatography Business JSR Life Sciences
DJ
Lesen
15. Okt. 2025, 12:03 UTC
Merck KGaA to Buy Chromatography Business of JSR Life Sciences
DJ
Lesen
7. Aug. 2025, 08:04 UTC
Germany's Merck Misses Expectations on Weaker Electronics Performance -- Market Talk
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA Had Seen 2025 Group Ebitda Before Exceptional Items of EUR5.8B-EUR6.4B
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA Had Guided for 2025 Group Sales of EUR20.9B-EUR22.4B
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA Had Seen 2025 Organic Growth in Ebitda Before Exceptional Items at 2%-7%
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA Had Guided for 2025 Organic Sales Growth at 2%-6%
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA Now Sees 2025 Group Ebitda Before Exceptional Items of EUR5.9B-EUR6.3B
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA Now Sees 2025 Organic Growth in Ebitda Before Exceptional Items at 4%-8%
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA Cuts 2025 View To Sales EUR20.5B-EUR21.7B
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Analysts Saw Merck KGaA 2Q Sales at EUR5.32B
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA Now Expects 2025 Organic Sales Growth at 2%-5%
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Analysts Saw Merck KGaA 2Q Ebitda Before Exceptional Items at EUR1.52B
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA Says It Faced Strong Currency Headwinds
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA Adjusts 2025 View
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA Raises 2025 Guidance for Organic Growth in Ebitda Before Exceptional Items
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA Narrows 2025 Organic Sales Growth Guidance
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA 2Q EBITDA EUR1.35B
DJ
Lesen
7. Aug. 2025, 05:00 UTC
Merck KGaA 2Q After-Tax Profit EUR655M
DJ
Lesen
Kursveränderung
By TipRanks
12-Monats-Prognose
Durchschnitt 143.14 EUR 30.48%
Hoch 182 EUR
Tief 120 EUR
Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Merck KGaA – Dist angeboten haben.
By TipRanks
Buy
8 ratings
5
Buy
3
Halten
0
Sell
Basierend auf 8 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Merck KGaA – Dist abgegeben haben.
By Trading Central
Kurzfristig
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Mittelfristig
Neutral Evidence
The bullish and bearish events are balanced.
Langfristig
Bearish Evidence
All events are bearish.
Vertriebs- und Verwaltungskosten
Betriebsaufwand
Gewinn vor Steuern
Verkäufe
Umsatzkosten
Bruttogewinn aus dem Verkauf
Zinsaufwand für Schulden
EBITDA
Betriebsergebnis
$